Indegene Limited's subsidiaries have acquired 100% equity in Trilogy Writing & Consulting Inc. (Canada) for EUR 329,014.00 in a cash deal. Trilogy Canada, specializing in medical writing, reported CAD 892,361.00 in turnover last year. This move is primarily an internal restructuring, consolidating medical writing capabilities under Indegene, Inc. The acquisition aims to streamline operations and enhance strategic alignment within Indegene's global healthcare services portfolio, reinforcing its presence in Canada. This represents a foundational step to integrate core functions more closely.